Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
- Emmanuel S. Antonarakis
- , Se Hoon Park
- , Jeffrey C. Goh
- , Sang Joon Shin
- , Jae Lyun Lee
- , Niven Mehra
- , Ray Mcdermott
- , Núria Sala-Gonzalez
- , Peter C. Fong
- , Richard Greil
- , Margitta Retz
- , Juan Pablo Sade
- , Patricio Yanez
- , Yi Hsiu Huang
- , Stephen D. Begbie
- , Rustem Airatovich Gafanov
- , Maria De Santis
- , Eli Rosenbaum
- , Michael P. Kolinsky
- , Felipe Rey
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
117
!!Link opens in a new tab
被引用数
(Scopus)